Duncan Barbara Gayle
Insider CIK 1353128 · INVA Director · MDGN Director · HALO Director · ICPT Chief Financial Officer · AVIR Director · ADAP Director · OVID Director · JNCE Director · FUSN Director · IMMU Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2026-06-18 | 2026-06-23 | 26,700 | — | $0 | 26,700 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-06-18 | 2026-06-23 | 29,600 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2026-06-18 | 2026-06-23 | 37,700 | — | $0 | 37,700 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2026-06-18 | 2026-06-23 | 29,600 | — | $0 | 92,350 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2026-05-05 | 2026-05-07 | 6,040 | — | $0 | 6,040 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2026-05-05 | 2026-05-07 | 3,796 | — | $0 | 23,715 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2026-02-26 | 2026-03-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2025-06-20 | 2025-06-24 | 29,600 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-06-20 | 2025-06-24 | 29,600 | — | $0 | 29,600 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-06-20 | 2025-06-24 | 41,200 | — | $0 | 41,200 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2025-06-20 | 2025-06-24 | 29,600 | — | $0 | 62,750 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2025-05-01 | 2025-05-02 | 5,750 | — | $0 | 5,750 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2025-05-01 | 2025-05-02 | 4,165 | — | $0 | 19,919 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2025-02-20 | 2025-06-18 | 45,000 | — | $0 | 45,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2024-12-12 | 2024-12-16 | 90,000 | — | $0 | 90,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2024-06-21 | 2024-06-21 | 41,200 | — | $0 | 41,200 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2024-06-21 | 2024-06-21 | 29,600 | — | $0 | 29,600 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2024-06-16 | 2024-06-18 | 33,150 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2024-06-16 | 2024-06-18 | 33,150 | — | $0 | 33,150 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 30,000 | — | $0 | 0 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2024-04-25 | 2024-04-29 | 8,804 | — | $0 | 8,804 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2024-04-25 | 2024-04-29 | 6,501 | — | $0 | 15,754 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2024-02-22 | 2024-02-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 46,750 | — | $0 | 46,750 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 33,150 | — | $0 | 33,150 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2023-06-14 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2023-05-05 | 2023-05-09 | 11,371 | — | $0 | 11,371 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2023-05-05 | 2023-05-09 | 8,065 | — | $0 | 9,253 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 10,840 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 34,271 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 13,550 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,700 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 20,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,700 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | D To issuer deriv | 2023-05-03 | 2023-05-04 | 15,700 | — | $0 | 0 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2023-02-03 | 2023-02-07 | 1,188 | — | $0 | 1,188 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-07-01 | 2022-07-01 | 500,000 | — | $0 | 500,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2022-06-24 | 2022-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2022-06-17 | 2022-06-21 | 61,264 | — | $0 | 61,264 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2022-06-14 | 2022-06-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2022-04-08 | 2022-04-12 | 21,347 | — | $0 | 21,347 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2022-02-03 | 2022-02-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2021-07-01 | 2021-07-02 | 379,788 | — | $0 | 379,788 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2021-06-18 | 2021-06-21 | 34,025 | — | $0 | 34,025 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-06-18 | 2021-06-22 | 15,700 | — | $0 | 15,700 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2021-06-11 | 2021-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2021-06-04 | 2021-06-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2021-05-17 | 2021-05-18 | 1,750 | — | $0 | 1,750 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2020-10-30 | 2020-11-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2020-10-29 | 2020-10-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| IMMU IMMUNOMEDICS INC | D To issuer deriv | 2020-10-23 | 2020-10-23 | 3,718 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | D To issuer deriv | 2020-10-23 | 2020-10-23 | 6,540 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | D To issuer | 2020-10-23 | 2020-10-23 | 49,244 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2020-09-15 | 2020-09-16 | 10,000 | — | $0 | 34,271 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-09-15 | 2020-09-16 | 5,000 | $10.50 | $52.5K | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-09-15 | 2020-09-16 | 5,000 | $9.50 | $47.5K | 5,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2020-09-15 | 2020-09-16 | 10,000 | $4.21 | $42.1K | 10,000 | SEC↗ |
| IMMU IMMUNOMEDICS INC | M Exercise deriv | 2020-09-14 | 2020-09-15 | 2,500 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | M Exercise | 2020-09-14 | 2020-09-15 | 2,500 | $16.96 | $42.4K | 39,577 | SEC↗ |
| IMMU IMMUNOMEDICS INC | M Exercise deriv | 2020-08-17 | 2020-08-20 | 20,000 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | M Exercise | 2020-08-17 | 2020-08-20 | 20,000 | $16.96 | $339.2K | 37,077 | SEC↗ |
| IMMU IMMUNOMEDICS INC | M Exercise deriv | 2020-08-12 | 2020-08-14 | 17,077 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | M Exercise | 2020-08-12 | 2020-08-14 | 17,077 | $12.93 | $220.8K | 17,077 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2020-07-01 | 2020-07-01 | 144,000 | — | $0 | 144,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-06-26 | 2020-07-02 | 15,700 | — | $0 | 15,700 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-06-26 | 2020-06-29 | 13,550 | — | $0 | 13,550 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2020-06-18 | 2020-06-22 | 6,540 | — | $0 | 6,540 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award | 2020-06-18 | 2020-06-22 | 3,718 | — | $0 | 13,385 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2020-06-05 | 2020-06-08 | 13,250 | — | $0 | 13,250 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 50,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 10,591 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 20,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 20,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 40,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer | 2020-02-03 | 2020-02-05 | 59,524 | — | $0 | 0 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2019-11-13 | 2019-11-15 | 7,437 | — | $0 | 7,437 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-07-02 | 2019-07-03 | 124,000 | — | $0 | 124,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-13 | 15,700 | — | $0 | 15,700 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2019-06-10 | 2019-08-01 | 5,813 | — | $0 | 5,813 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2019-06-07 | 2019-06-10 | 5,813 | — | $0 | 5,813 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2019-06-07 | 2019-06-11 | 17,077 | — | $0 | 17,077 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award | 2019-06-07 | 2019-06-11 | 9,667 | — | $0 | 9,667 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2019-03-05 | 2019-03-07 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2018-06-22 | 2018-06-26 | 158,233 | — | $0 | 158,233 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2018-06-19 | 2018-06-21 | 13,550 | — | $0 | 13,550 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | A Award deriv | 2018-06-14 | 2018-07-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | A Award deriv | 2018-06-14 | 2018-06-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 5,813 | — | $0 | 5,813 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2018-03-15 | 2018-03-19 | 2,000 | — | $0 | 44,271 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2018-03-15 | 2018-03-19 | 2,000 | $4.21 | $8.4K | 2,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2018-03-15 | 2018-03-19 | 2,000 | $28.11 | $56.2K | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2018-01-26 | 2018-01-29 | 4,000 | $4.21 | $16.8K | 46,271 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2018-01-26 | 2018-01-29 | 4,000 | $4.21 | $16.8K | 4,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2018-01-26 | 2018-01-29 | 4,000 | $25.00 | $100.0K | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | P Buy deriv | 2017-10-17 | 2017-10-18 | 10,591 | — | $0 | 10,591 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | P Buy | 2017-10-17 | 2017-10-18 | 59,524 | $1.26 | $75.0K | 59,524 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2017-07-03 | 2017-07-03 | 228,765 | — | $0 | 228,765 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | A Award deriv | 2017-06-22 | 2017-08-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2017-06-14 | 2017-06-15 | 11,627 | — | $0 | 11,627 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2017-04-20 | 2017-04-24 | 19,857 | — | $0 | 52,318 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2016-11-18 | 2016-11-21 | 32,461 | — | $0 | 32,461 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-10-03 | 2016-10-05 | 147 | $163.20 | $24.0K | 30,661 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-07-05 | 2016-07-07 | 146 | $145.11 | $21.2K | 30,808 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2016-04-15 | 2016-04-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-04-04 | 2016-04-06 | 144 | $130.76 | $18.8K | 30,948 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2016-02-10 | 2016-02-12 | 8,100 | — | $0 | 8,100 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2016-02-10 | 2016-02-12 | 6,200 | — | $0 | 31,092 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-01-04 | 2016-01-05 | 40 | $145.90 | $5.8K | 25,320 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2016-01-04 | 2016-01-05 | 428 | $145.90 | $62.4K | 24,892 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2016-01-01 | 2016-01-05 | 1,298 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2016-01-01 | 2016-01-05 | 1,298 | — | $0 | 25,360 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-10-02 | 2015-10-05 | 54 | $159.04 | $8.6K | 24,062 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-10-01 | 2015-10-05 | 1,298 | — | $0 | 1,298 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-10-01 | 2015-10-05 | 1,000 | — | $0 | 6,940 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2015-10-01 | 2015-10-05 | 10,600 | — | $0 | 10,600 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-10-01 | 2015-10-05 | 1,298 | — | $0 | 25,116 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-10-01 | 2015-10-05 | 1,000 | $163.39 | $163.4K | 24,116 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2015-10-01 | 2015-10-05 | 4,050 | — | $0 | 22,818 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-10-01 | 2015-10-05 | 1,000 | $8.67 | $8.7K | 23,818 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2015-07-22 | 2015-07-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2015-07-22 | 2015-08-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-07-02 | 2015-07-07 | 1 | $239.00 | $239 | 18,768 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-07-02 | 2015-07-07 | 50 | $236.13 | $11.8K | 18,771 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-07-02 | 2015-07-07 | 2 | $238.16 | $476 | 18,769 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-07-01 | 2015-07-06 | 1,000 | — | $0 | 7,940 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-07-01 | 2015-07-07 | 1,298 | — | $0 | 2,596 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-07-01 | 2015-07-06 | 1,000 | $242.10 | $242.1K | 17,523 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-07-01 | 2015-07-06 | 1,000 | $8.67 | $8.7K | 18,523 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-07-01 | 2015-07-07 | 1,298 | — | $0 | 18,821 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-04-02 | 2015-04-03 | 39 | $277.70 | $10.8K | 17,523 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-04-01 | 2015-04-03 | 1,298 | — | $0 | 3,894 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-04-01 | 2015-04-03 | 1,298 | — | $0 | 17,562 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-27 | 2015-04-01 | 100 | $291.00 | $29.1K | 16,664 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-27 | 2015-04-01 | 100 | $289.00 | $28.9K | 16,764 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-27 | 2015-04-01 | 100 | $288.00 | $28.8K | 16,864 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-27 | 2015-04-01 | 100 | $285.00 | $28.5K | 17,164 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-27 | 2015-04-01 | 100 | $286.00 | $28.6K | 17,064 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-27 | 2015-04-01 | 100 | $292.16 | $29.2K | 16,564 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-27 | 2015-04-01 | 100 | $287.00 | $28.7K | 16,964 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-27 | 2015-04-01 | 300 | $293.34 | $88.0K | 16,264 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-01-05 | 2015-01-07 | 141 | $176.49 | $24.9K | 17,264 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-01-02 | 2015-01-05 | 1,000 | — | $0 | 14,875 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-01-02 | 2015-01-05 | 500 | $158.35 | $79.2K | 17,405 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-01-02 | 2015-01-05 | 500 | $154.45 | $77.2K | 17,905 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-01-02 | 2015-01-05 | 1,000 | $31.90 | $31.9K | 18,405 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-01-01 | 2015-01-05 | 1,298 | — | $0 | 5,192 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-01-01 | 2015-01-05 | 1,298 | — | $0 | 17,405 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-10-01 | 2014-10-03 | 1,000 | — | $0 | 15,875 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-10-01 | 2014-10-03 | 1,299 | — | $0 | 6,490 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-10-01 | 2014-10-03 | 1,000 | $31.90 | $31.9K | 17,107 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 900 | $232.92 | $209.6K | 16,207 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-10-01 | 2014-10-03 | 100 | $234.87 | $23.5K | 16,107 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-10-01 | 2014-10-03 | 1,299 | — | $0 | 16,107 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-07-01 | 2014-07-03 | 1,298 | — | $0 | 7,789 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-07-01 | 2014-07-03 | 1,298 | — | $0 | 14,808 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-04-14 | 2014-04-15 | 1,154 | — | $0 | 8,365 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-04-14 | 2014-04-15 | 1,154 | $21.50 | $24.8K | 14,664 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-04-14 | 2014-04-15 | 1,154 | $279.00 | $322.0K | 13,510 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2014-04-11 | 2014-04-15 | 1,835 | — | $0 | 1,835 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2014-04-11 | 2014-04-15 | 6,650 | — | $0 | 6,650 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2014-04-11 | 2014-04-15 | 1,504 | — | $0 | 13,510 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-04-01 | 2014-04-03 | 1,298 | — | $0 | 9,087 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-04-01 | 2014-04-03 | 1,298 | — | $0 | 12,006 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-01-15 | 2014-01-17 | 5,625 | — | $0 | 16,875 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 300 | $251.55 | $75.5K | 16,033 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-01-15 | 2014-01-17 | 5,625 | $31.90 | $179.4K | 16,333 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 500 | $256.00 | $128.0K | 13,883 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 500 | $255.00 | $127.5K | 14,383 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 500 | $258.30 | $129.2K | 12,633 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 250 | $283.90 | $71.0K | 10,708 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 125 | $280.00 | $35.0K | 10,958 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 50 | $274.00 | $13.7K | 11,083 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 250 | $265.00 | $66.3K | 11,133 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 250 | $264.00 | $66.0K | 11,383 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 250 | $263.00 | $65.8K | 11,633 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 250 | $262.00 | $65.5K | 11,883 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 500 | $260.00 | $130.0K | 12,133 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 1,150 | $253.63 | $291.7K | 14,883 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-01-15 | 2014-01-17 | 750 | $257.27 | $193.0K | 13,133 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-01-01 | 2014-01-03 | 1,298 | — | $0 | 10,385 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-01-01 | 2014-01-03 | 1,298 | — | $0 | 10,708 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-10-01 | 2013-10-03 | 1,298 | — | $0 | 11,683 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-10-01 | 2013-10-03 | 1,298 | — | $0 | 9,410 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-07-08 | 2013-07-10 | 25,000 | — | $0 | 19,520 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-07-08 | 2013-07-10 | 25,000 | $45.39 | $1.13M | 8,112 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-07-08 | 2013-07-10 | 25,000 | $9.82 | $245.5K | 33,112 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-07-01 | 2013-07-03 | 1,298 | — | $0 | 12,981 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-07-01 | 2013-07-03 | 1,298 | — | $0 | 8,112 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-06-19 | 2013-06-21 | 8,557 | — | $0 | 8,940 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-06-19 | 2013-06-21 | 42,018 | — | $0 | 44,520 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-06-19 | 2013-06-21 | 8,557 | $8.67 | $74.2K | 14,741 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-06-19 | 2013-06-21 | 42,018 | $9.82 | $412.6K | 56,759 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-06-19 | 2013-06-21 | 50,575 | $34.50 | $1.74M | 6,814 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-05-28 | 2013-05-28 | 4,915 | — | $0 | 17,497 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-05-28 | 2013-05-28 | 4,915 | $8.67 | $42.6K | 11,729 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-05-28 | 2013-05-28 | 4,915 | $34.50 | $169.6K | 6,814 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-05-24 | 2013-05-28 | 1,200 | — | $0 | 22,412 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-05-24 | 2013-05-28 | 1,200 | $34.50 | $41.4K | 6,814 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-05-24 | 2013-05-28 | 1,200 | $8.67 | $10.4K | 8,014 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-05-23 | 2013-05-28 | 110 | — | $0 | 23,612 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-05-23 | 2013-05-28 | 110 | $34.54 | $3.8K | 6,814 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-05-23 | 2013-05-28 | 110 | $8.67 | $954 | 6,924 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-05-20 | 2013-05-22 | 4,327 | — | $0 | 9,519 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-05-20 | 2013-05-22 | 23,873 | — | $0 | 23,722 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-05-20 | 2013-05-22 | 4,327 | $21.50 | $93.0K | 11,141 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-05-20 | 2013-05-22 | 28,000 | $34.50 | $966.0K | 7,014 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-05-20 | 2013-05-22 | 100 | $34.50 | $3.5K | 6,914 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-05-20 | 2013-05-22 | 100 | $34.50 | $3.5K | 6,814 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-05-20 | 2013-05-22 | 23,873 | $8.67 | $207.0K | 35,014 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2013-05-07 | 2013-05-09 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2013-05-07 | 2013-05-09 | 3,000 | — | $0 | 6,814 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-04-09 | 2013-04-11 | 6,490 | — | $0 | 14,279 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | F Tax w/h | 2013-04-09 | 2013-04-11 | 2,676 | $34.57 | $92.5K | 3,814 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-04-09 | 2013-04-11 | 6,490 | — | $0 | 6,490 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2012-11-16 | 2012-11-20 | 20,769 | — | $0 | 20,769 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2012-11-16 | 2012-11-20 | 13,846 | — | $0 | 13,846 | SEC↗ |